Review
Open access
Aug 2026
Ethical and social recognition of participation in drug clinical trials: French public views on financial compensation for participants
Background Drug clinical trial participants should be fairly compensated for inconvenience while avoiding undue inducement. However, European regulations provide limited operational guidance on when compensation should be offered and how it should be determined. The INDEM3 project aims to develop a decision-support too...
L. Peyro-Saint-Paul, C. Gaillard, C. Berchi et al.
· PLoS ONE · 0 citations